HIF1A and hepatocellular carcinoma: Interestingly, it was proposed that miR-210 could contribute to the HIF switch between HIF-1/HIF-2 and HIF-3 in human chondrocytes [45] and hepatocellular carcinoma cells [46] as miR-210 directly targets HIF-3α and suppresses HIF-1α protein expression.